Central post stroke pain: clinical, MRI, and SPECT correlation

Area of Science:

• Neurology
• Neuroimaging
• Pain Medicine

Background:

• Central post-stroke pain (CPSP) is a debilitating neurological condition resulting from stroke-induced damage to the somatosensory pathways.
• Understanding the clinical spectrum and neuroimaging correlates of CPSP is crucial for effective diagnosis and management.
• Quantitative sensory testing (QST) provides objective measures of sensory dysfunction in pain conditions.

Purpose of the Study:

• To characterize the clinical presentation of central post-stroke pain (CPSP).
• To correlate clinical findings with magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT) in CPSP patients.
• To investigate the relationship between QST findings and neuroimaging results in CPSP.

Main Methods:

• A prospective study involving 23 consecutive patients with CPSP was conducted at a tertiary care teaching hospital.
• Quantitative sensory testing (QST) assessed pain severity, sensory thresholds, allodynia, hyperalgesia, and temporal summation.
• Cranial MRI and technetium-99m ethylene cystine dimmer SPECT were performed and correlated with QST findings.

Main Results:

• QST findings were comparable between patients with thalamic and extrathalamic CPSP lesions.
• MRI revealed infarction in 14 patients and hematoma in nine patients.
• SPECT showed abnormalities in 17 patients, with hypoperfusion in the thalamus (n=9) and parietal cortex (n=11); however, MRI and SPECT findings did not differ in patients with or without allodynia.

Conclusions:

• Clinical and QST characteristics of CPSP are similar irrespective of whether the lesion is located in the thalamus or extrathalamic regions.
• Neuroimaging findings (MRI and SPECT) do not differentiate CPSP patients based on the presence or absence of allodynia.
• Further research is needed to elucidate the complex mechanisms underlying CPSP and identify specific imaging biomarkers.